Brief: Terns Pharmaceuticals Announces Orphan Drug Designation Granted To TERN-701
11/03/2024 20:20
March 11 (Reuters) - Terns Pharmaceuticals Inc TERN.O :
* TERNS PHARMACEUTICALS ANNOUNCES ORPHAN DRUG DESIGNATION
GRANTED
TO TERN-701 FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA
Source text for Eikon: ID:nGNX5B03nL
Further company coverage: TERN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Terns Pharmaceuticals
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
Brief: Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.